Comera Life Sciences Holdings - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CMRA Nasdaq 8731 https://www.comeralifesciences.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Comera Life Sciences Holdings

Comera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights - Mar 16th, 2023 12:00 pm
Comera Life Sciences to Present at 22nd Annual PepTalk Conference - Jan 12th, 2023 9:15 pm
Comera Life Sciences to Present at Upcoming Biotech Showcase Investor Conference - Jan 5th, 2023 1:00 pm
Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq Rules - Jan 4th, 2023 9:15 pm
Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference - Nov 17th, 2022 9:05 pm
Comera Life Sciences Reports Financial Results for Third Quarter 2022 and Business Highlights - Nov 10th, 2022 1:00 pm
Comera Life Sciences Appoints Janice Marie McCourt as Chief Business Officer - Nov 9th, 2022 1:00 pm
Comera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 Study - Oct 18th, 2022 12:00 pm
Comera Life Sciences Expands Woburn Operations - Oct 4th, 2022 2:30 pm
Comera Life Sciences Announces Up To $15 million Purchase Agreement with Arena Business Solutions - Aug 31st, 2022 8:15 pm
Comera Life Sciences to Present Topline Results of SEQURUS-2 Study at 14th Annual Bioprocessing Summit - Aug 11th, 2022 12:00 pm
Comera Life Sciences Provides Business Highlights and Reports Financial Results for the Second Quarter 2022 - Aug 10th, 2022 8:15 pm
Comera Life Sciences Announces Issuance of U.S. Patent for Proprietary Excipients in SQore Platform - Jun 22nd, 2022 12:00 pm
Comera Life Sciences Appoints Michael Campbell as Executive Vice President and Chief Financial Officer - Jun 16th, 2022 12:00 pm